The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

RAS/RAF Mutations and New Approaches in CRC: Onvansertib+Irinotecan for KRASm, Enco+Bini+Cetux in BRAF V600Em, NGS in mCRC

20 views
May 17, 2021
Comments 0
Login to view comments. Click here to Login